CN116549555A - Cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by liver-lung yin deficiency - Google Patents
Cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by liver-lung yin deficiency Download PDFInfo
- Publication number
- CN116549555A CN116549555A CN202310497253.3A CN202310497253A CN116549555A CN 116549555 A CN116549555 A CN 116549555A CN 202310497253 A CN202310497253 A CN 202310497253A CN 116549555 A CN116549555 A CN 116549555A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- liver
- cyclodextrin
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 96
- 206010011224 Cough Diseases 0.000 title claims abstract description 73
- 208000031971 Yin Deficiency Diseases 0.000 title claims abstract description 37
- 206010062717 Increased upper airway secretion Diseases 0.000 title claims description 34
- 208000026435 phlegm Diseases 0.000 title claims description 34
- 239000002131 composite material Substances 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 27
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 24
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 24
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 24
- 229960004853 betadex Drugs 0.000 claims abstract description 24
- 210000004072 lung Anatomy 0.000 claims abstract description 23
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 21
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 21
- 210000004185 liver Anatomy 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 17
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 13
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 13
- 241001547127 Fritillaria cirrhosa Species 0.000 claims abstract description 10
- 244000236658 Paeonia lactiflora Species 0.000 claims abstract description 10
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims abstract description 10
- 206010036790 Productive cough Diseases 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 230000001105 regulatory effect Effects 0.000 claims abstract description 6
- 208000024794 sputum Diseases 0.000 claims abstract description 5
- 210000003802 sputum Anatomy 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 23
- 239000008367 deionised water Substances 0.000 claims description 15
- 229910021641 deionized water Inorganic materials 0.000 claims description 15
- 239000006286 aqueous extract Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000002002 slurry Substances 0.000 claims description 9
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims description 9
- 238000009833 condensation Methods 0.000 claims description 8
- 230000005494 condensation Effects 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 3
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 3
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 241000935235 Fritillaria meleagris Species 0.000 abstract description 13
- 241000736199 Paeonia Species 0.000 abstract description 8
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 8
- 239000013543 active substance Substances 0.000 abstract description 7
- 238000000605 extraction Methods 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000000975 bioactive effect Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 3
- 239000001257 hydrogen Substances 0.000 abstract description 3
- 230000002209 hydrophobic effect Effects 0.000 abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 3
- 230000003993 interaction Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 239000000370 acceptor Substances 0.000 abstract 1
- 239000003337 fertilizer Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 229940126680 traditional chinese medicines Drugs 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 6
- 210000004243 sweat Anatomy 0.000 description 6
- 235000021028 berry Nutrition 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 238000009835 boiling Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940126673 western medicines Drugs 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 244000061508 Eriobotrya japonica Species 0.000 description 2
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 description 1
- QNVKOSLOVOTXKF-UHFFFAOYSA-N 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1 QNVKOSLOVOTXKF-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000218671 Ephedra Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960000985 ambroxol hydrochloride Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000024753 bloody sputum Diseases 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 239000008779 ma-xing-shi-gan-tang Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating cough and reducing sputum caused by liver-lung yin deficiency, which belongs to the technical field of fertilizer traditional Chinese medicine preparations and comprises the following raw materials in parts by mass: 4-8 parts of fritillaria cirrhosa, 1-5 parts of cassia twig, 1-3 parts of schisandra chinensis, 1-3 parts of paeonia lactiflora and a plurality of auxiliary materials. The Chinese herbaceous peony and fritillary bulb are used for benefiting the yin of the liver and the lung, the cassia twig is used for dispelling exterior and eliminating cold evil, the schisandra fruit is used for astringing the yin of the lung, and the fritillary bulb and the cassia twig are used for promoting blood circulation and regulating the liver and the lung. The beta-cyclodextrin and the modified derivative thereof are used as auxiliary materials to assist in extracting active ingredients in the composite traditional Chinese medicine, and the hydroxyl groups and the glycosidic ether bonds contained in the beta-cyclodextrin and the modified derivative thereof can interact with acceptors and donors of hydrogen bonds and have hydrophobic interactions, so that the beta-cyclodextrin and the modified derivative thereof load traditional Chinese medicine active substances with poor water solubility, the extraction efficiency of bioactive ingredients is improved, the medicine effect is improved, the time required for rehabilitation is reduced, and the beta-cyclodextrin and the modified derivative thereof have the characteristics of strong specificity, good medicine effect and no side effect.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine preparations, and particularly relates to a traditional Chinese medicine for treating cough caused by liver-lung yin deficiency and resolving phlegm.
Background
At present, the medicines for treating cough and asthma on the market can be divided into western medicines and traditional Chinese medicines. The western medicines comprise dextromethorphan hydrobromide, pseudoephedrine hydrochloride, ambroxol hydrochloride and the like, the medicinal components are single, the medicinal components are often used in a combined way, and side effects on cardiovascular systems and the like of human bodies can be caused, and if the medicinal components are improperly used, fatal risks can be caused. And western medicines are mostly used for relieving the cold surface symptoms, namely treating the symptoms without treating the root cause, have single components, and cannot well solve a plurality of main complaints of patients.
Although there are few traditional Chinese medicines for treating cough and asthma in the market, because of different properties of compatible medicinal components, the object treated by each traditional Chinese medicine is also a certain type of cold, which is represented by loquat dew, lung-moistening cream, pummelo peel cream, suhuang cough and cough, and the like, and most of the traditional Chinese medicines are mainly used for treating wind-heat or wind-cold type cough.
"Huangdi's interior channel, su, ke Lun" cloud: cough with cough in both viscera and lung, but not in the sole lung.
Patients with cough and visit have symptoms mainly caused by deficiency of liver-yin and lung-yin and deficiency of stomach-yin, and mainly caused by sweating, thirst, cough, dyspnea, yellowish phlegm, poor appetite and irritability. In Ma xing Shi Gan Tang from Shang Han Lun, lung cough is mainly caused by excessive cough and deficiency syndrome is not middle energizer, and Ma Huang is contraindicated for deficiency sweat. The cough relieving and phlegm reducing Chinese patent medicines on the market at present have no good solution, such as fritillary and loquat leaf extract, and have the effects of reducing phlegm, relieving cough and nourishing yin, but the curative effect on yin deficiency and cough caused by yin deficiency of liver and lung is poor because the medicine efficacy of the Chinese patent medicine is not as good as that of liver and stomach.
In addition, most of traditional Chinese medicines are decocted with water, but partial active substances in traditional Chinese medicine plants have low solubility in water, so that the traditional Chinese medicines have the problems of small effect, long recovery time and the like when the traditional Chinese medicines exert the efficacy.
Disclosure of Invention
The invention aims to provide a cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by liver-lung yin deficiency, which is used for treating cough caused by liver-lung yin deficiency by using a combination of four traditional Chinese medicines including fritillaria cirrhosa, cassia twig, schisandra chinensis and paeonia lactiflora. The Chinese herbaceous peony and fritillary bulb are used for benefiting the yin of the liver and the lung, the cassia twig is used for dispelling exterior and eliminating cold evil, the schisandra fruit is used for astringing the yin of the lung, and the fritillary bulb and the cassia twig are used for promoting blood circulation and regulating the liver and the lung. The beta-cyclodextrin and its modified derivative are used to assist in extracting active components in the composite traditional Chinese medicine, and the hydroxyl group and glycosidic ether bond contained in the beta-cyclodextrin and its modified derivative can interact with the acceptor and donor of hydrogen bond, and the hydrophobic interaction of the beta-cyclodextrin and its modified derivative can load traditional Chinese medicine active substances with poor water solubility, so that the extraction efficiency of bioactive components is improved, the medicine effect is improved, the time required for rehabilitation is reduced, and the composite traditional Chinese medicine has the characteristics of strong specificity, good medicine effect and no side effect.
The invention aims to solve the technical problems:
the invention solves the problems that the traditional Chinese medicine prescription has poor curative effect when treating cough, expectoration and asthma caused by deficiency of liver-lung yin or deficiency of stomach-yin of a patient, and the existing traditional Chinese medicine prescription aims at the blank cough and asthma caused by deficiency of liver-lung yin and has smaller water solubility of active substances in the traditional Chinese medicine, so that the abundance of the active substances in the traditional Chinese medicine prescription is low.
The aim of the invention can be achieved by the following technical scheme:
a traditional Chinese medicine for treating cough and resolving phlegm caused by liver-lung yin deficiency comprises the following components:
4-8 parts of fritillaria cirrhosa, 1-5 parts of cassia twig, 1-3 parts of schisandra chinensis, 1-3 parts of paeonia lactiflora and 7-95 parts of auxiliary materials.
A traditional Chinese medicine for treating cough caused by liver-lung yin deficiency with cough relieving and phlegm resolving functions, the preparation method comprises the following steps:
s1, washing the traditional Chinese medicine materials with deionized water for 3 times, cutting into blocks, sun-drying, then crushing into coarse powder, sieving with a 80-mesh sieve to obtain composite traditional Chinese medicine powder, and storing at 4 ℃ for later use;
s2, soaking the composite traditional Chinese medicine powder in deionized water at room temperature for 1 hour, then adding auxiliary materials, stirring at a speed of 30rpm until the mixture is uniform, and performing condensation reflux operation to obtain an aqueous extract of the composite traditional Chinese medicine;
s3, spray drying the composite traditional Chinese medicine aqueous extract, wherein the temperature of an inlet is set to 80 ℃, the temperature of an outlet is set to 40 ℃, collecting dry powder, and preparing pills to obtain the cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by yin deficiency of liver and lung.
Further, in the step S2, the mass ratio of the composite traditional Chinese medicine powder to the deionized water is (75-80): 800, the condensation reflux time was 2 hours.
Further, the auxiliary material is one or more of alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Further, the hydroxypropyl-beta-cyclodextrin is prepared by the steps of:
stirring NaOH solution at 30rpm, heating to 60 ℃, adding beta-cyclodextrin while keeping stirring, continuing stirring until the beta-cyclodextrin is completely dissolved, cooling the system to room temperature, then dropwise adding propylene oxide while stirring under ice bath, reacting for 3 hours, heating to room temperature, continuing stirring until an oil layer disappears, regulating the pH value of the system to 6-7 by using HCl solution, then distilling the mixed solution at 45 ℃ under reduced pressure to obtain slurry, dissolving the slurry by using 95% ethanol solution, continuing stirring for 30 minutes, filtering, discarding the precipitate, distilling the filtrate at 45 ℃ under reduced pressure until the volume is 1/3 of the volume, dialyzing with water for 3 hours, then standing at 45 ℃ again under reduced pressure, washing the obtained concentrated slurry by acetone, and drying to obtain the hydroxypropyl-beta-cyclodextrin.
The invention has the beneficial effects that:
(1) In the technical scheme of the invention, the combination of four traditional Chinese medicines including fritillaria cirrhosa, cassia twig, schisandra chinensis and paeonia lactiflora is used for treating cough caused by yin deficiency of liver and lung. According to the theory of traditional Chinese medicine, yin herbs are heavy in property, so that the gram number is increased, and the volume is the same as that of yang herbs. Regulating the dosage of the medicine, increasing the dosage of the fritillary bulb, and treating yin with yang (even) and treating yin with yang (odd). The Chinese herbaceous peony and fritillary bulb are used for benefiting the yin of the liver and the lung, the cassia twig is used for dispelling exterior and eliminating cold evil, the schisandra fruit is used for astringing the yin of the lung, and the fritillary bulb and the cassia twig are used for promoting blood circulation and regulating the liver and the lung. Cough with sputum due to yin deficiency caused by the season throttled influenza can be eradicated within 3 days, and all complications caused by seasonal influenza such as: the symptoms of liver-lung yin deficiency related to thirst, sweat, nasal discharge, sneeze, light yellow phlegm, deficiency asthma, and frequent sighing can also disappear, and the traditional Chinese medicine has good treatment effect.
(2) In the technical scheme of the invention, the beta-cyclodextrin and the modified derivative thereof are used for assisting in extracting active ingredients in the compound traditional Chinese medicine, the cyclodextrin has the characteristic of improving the solubility, bioavailability and stability of guest molecules by forming inclusion complex, all the ingredients are natural ingredients, no hormone ingredients are contained, the active ingredients are easier to be absorbed by human bodies, no toxic or side effect is caused on the human bodies, the stability and the moisture-proof capacity of the medicine storage are improved, and the curative effect is remarkable.
(3) In the technical scheme of the invention, the hydroxyl group and the glycosidic ether bond contained on the beta-cyclodextrin and the modified derivative thereof can interact with an acceptor and a donor of a hydrogen bond, and the beta-cyclodextrin and the modified derivative thereof have hydrophobic interaction, so that the beta-cyclodextrin and the modified derivative thereof load traditional Chinese medicine active substances with poor water solubility, the extraction efficiency of bioactive components is improved, the drug effect is improved, and the time required for rehabilitation is reduced.
(4) In the technical scheme of the invention, common traditional Chinese medicine combinations are adopted, less kinds of collocations are used, the medicine property of the traditional Chinese medicines is reasonably utilized, the applicable population is increased, and the possible side effect risk is reduced. The common cough traditional Chinese medicines such as ephedra herb and liquorice are not suitable for patients with excessive phlegm, phlegm dampness, large sweat or hemorrhagic diseases, so that the treatment effect of the medicine is different from person to person. Compared with all the existing cold medicines, the formula in the technical scheme not only can treat all complications caused by seasonal influenza viruses in a short period, but also can not cause burden to human kidneys, and has the characteristics of safety and effectiveness.
Detailed Description
The technical solutions of the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention, and it is apparent that the described embodiments are only some embodiments of the present invention, not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1
A traditional Chinese medicine for treating cough and resolving phlegm caused by liver-lung yin deficiency comprises the following components:
40g of fritillaria cirrhosa, 10g of cassia twig, 10g of schisandra chinensis, 10g of paeonia lactiflora and 8g of beta-cyclodextrin.
A traditional Chinese medicine for treating cough caused by liver-lung yin deficiency with cough relieving and phlegm resolving functions, the preparation method comprises the following steps:
s1, washing fritillary bulb, cassia twig, shizandra berry and Chinese herbaceous peony traditional Chinese medicine materials with deionized water for 3 times, cutting into blocks, sun-drying, then crushing into coarse powder, sieving with a 80-mesh sieve, mixing according to the formula parts by weight, obtaining composite traditional Chinese medicine powder, and storing at 4 ℃ for later use;
s2, soaking 70g of the composite traditional Chinese medicine powder in 800mL of deionized water at room temperature for 1 hour, then adding beta-cyclodextrin, stirring at a speed of 30rpm until the mixture is uniform, and performing condensation reflux operation to obtain an aqueous extract of the composite traditional Chinese medicine;
s3, spray drying the composite traditional Chinese medicine aqueous extract, wherein the temperature of an inlet is set to 80 ℃, the temperature of an outlet is set to 40 ℃, collecting dry powder, and preparing pills to obtain the cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by yin deficiency of liver and lung.
Example 2
A traditional Chinese medicine for treating cough and resolving phlegm caused by liver-lung yin deficiency comprises the following components:
30g of fritillaria cirrhosa, 15g of cassia twig, 10g of schisandra chinensis, 10g of paeonia lactiflora and 20g of beta-cyclodextrin.
A traditional Chinese medicine for treating cough caused by liver-lung yin deficiency with cough relieving and phlegm resolving functions, the preparation method comprises the following steps:
s1, washing fritillary bulb, cassia twig, shizandra berry and Chinese herbaceous peony traditional Chinese medicine materials with deionized water for 3 times, cutting into blocks, sun-drying, then crushing into coarse powder, sieving with a 80-mesh sieve, mixing according to the formula parts by weight, obtaining composite traditional Chinese medicine powder, and storing at 4 ℃ for later use;
s2, soaking 65g of the composite traditional Chinese medicine powder in 800mL of deionized water at room temperature for 1 hour, then adding 20g of beta-cyclodextrin, stirring at a speed of 30rpm until the mixture is uniform, and performing condensation reflux operation to obtain an aqueous extract of the composite traditional Chinese medicine;
s3, spray drying the composite traditional Chinese medicine aqueous extract, wherein the temperature of an inlet is set to 80 ℃, the temperature of an outlet is set to 40 ℃, collecting dry powder, and preparing pills to obtain the cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by yin deficiency of liver and lung.
Example 3
A traditional Chinese medicine for treating cough and resolving phlegm caused by liver-lung yin deficiency comprises the following components:
32g of fritillaria cirrhosa, 20g of cassia twig, 12g of schisandra chinensis, 12g of paeonia lactiflora and 40g of hydroxypropyl-beta-cyclodextrin.
A traditional Chinese medicine for treating cough caused by liver-lung yin deficiency with cough relieving and phlegm resolving functions, the preparation method comprises the following steps:
s1, washing fritillary bulb, cassia twig, shizandra berry and Chinese herbaceous peony traditional Chinese medicine materials with deionized water for 3 times, cutting into blocks, sun-drying, then crushing into coarse powder, sieving with a 80-mesh sieve, mixing according to the formula parts by weight, obtaining composite traditional Chinese medicine powder, and storing at 4 ℃ for later use;
s2, stirring 14.1g of NaOH solution at a speed of 30rpm, heating to 60 ℃, adding 20g of beta-cyclodextrin under the condition of keeping stirring, continuing stirring until the beta-cyclodextrin is completely dissolved, cooling the system to room temperature, then dropwise adding 15.2g of propylene oxide under ice bath while stirring, reacting for 3 hours, heating to room temperature, continuing stirring until an oil layer disappears, adjusting the pH value of the system to 6.8 by using HC (hydrogen carbonate) solution, then distilling the mixed solution under reduced pressure at 45 ℃ to obtain slurry, dissolving the slurry by using 95% ethanol solution, continuing stirring for 30 minutes, filtering, discarding the precipitate, distilling the filtrate under reduced pressure at 45 ℃ until the volume is 1/3 of the original volume, dialyzing the filtrate with water for 3 hours, then standing at 45 ℃ again under reduced pressure, washing the obtained concentrated slurry by acetone, and drying to obtain the hydroxypropyl-beta-cyclodextrin.
S3, soaking 76g of the composite traditional Chinese medicine powder in 800mL of deionized water at room temperature for 1 hour, then adding 40g of hydroxypropyl-beta-cyclodextrin, stirring at a speed of 30rpm until the mixture is uniform, and performing condensation reflux operation to obtain an aqueous extract of the composite traditional Chinese medicine;
s4, spray drying the composite traditional Chinese medicine aqueous extract, wherein the temperature of an inlet is set to 80 ℃, the temperature of an outlet is set to 40 ℃, collecting dry powder, and preparing pills to obtain the cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by yin deficiency of liver and lung.
Example 4
The comparative example differs from example 2 in that the adjuvant used in this example is alpha-cyclodextrin.
Comparative example 1
A traditional Chinese medicine for treating cough and resolving phlegm caused by liver-lung yin deficiency comprises the following components:
30g of fritillaria cirrhosa, 15g of cassia twig, 10g of schisandra chinensis and 10g of paeonia lactiflora.
A preparation method of a traditional Chinese medicine for treating cough and reducing sputum caused by liver-lung yin deficiency comprises the following steps: s1, washing fritillary bulb, cassia twig, shizandra berry and Chinese herbaceous peony traditional Chinese medicine materials with deionized water for 3 times, cutting into blocks, sun-drying, then crushing into coarse powder, sieving with a 80-mesh sieve, mixing according to the formula parts by weight, obtaining composite traditional Chinese medicine powder, and storing at 4 ℃ for later use;
s2, soaking 65g of the composite traditional Chinese medicine powder in 800mL of deionized water at room temperature for 1 hour, and then performing condensation reflux operation to obtain an aqueous extract of the composite traditional Chinese medicine;
s3, spray drying the composite traditional Chinese medicine aqueous extract, wherein the temperature of an inlet is set to 80 ℃, the temperature of an outlet is set to 40 ℃, collecting dry powder, and preparing pills to obtain the cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by yin deficiency of liver and lung.
Comparative example 2
A traditional Chinese medicine for treating cough and resolving phlegm caused by liver-lung yin deficiency comprises the following components:
30g of fritillaria cirrhosa, 15g of cassia twig, 10g of schisandra chinensis and 10g of paeonia lactiflora.
A preparation method of a traditional Chinese medicine for treating cough and reducing sputum caused by liver-lung yin deficiency comprises the following steps:
s1, washing fritillary bulb, cassia twig, shizandra berry and Chinese herbaceous peony traditional Chinese medicine materials with deionized water for 3 times, cutting into blocks, sun-drying, and mixing according to the formula parts by weight to obtain a composite traditional Chinese medicine;
s2, adding 800g of water into the compound traditional Chinese medicine, boiling and boiling for 0.5h, adding 700g of water, boiling and boiling for 0.5h, filtering, and collecting filtrate to obtain the cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by liver-lung yin deficiency.
The pharmacological effects of the agents prepared in examples 1-4 and comparative examples 1-2 were now examined.
1. And selecting a case.
Cough patients caused by liver-lung yin deficiency or stomach-yin deficiency are selected, and the clinical manifestations are mainly cough asthma, emaciation, dry throat, dry cough, little phlegm, bloody sputum, hoarseness, afternoon hot flashes, cheekbone red, dysphoria with feverish sensation in the chest, night sweat, red tongue with little coating, thin and rapid pulse and other symptoms, and the cough patients can be seen as hoarseness, dry cough, no phlegm or difficult expectoration with little phlegm, and also have symptoms of asthma, dry mouth, insomnia, irritability, crying and sighing and the like.
2. Efficacy verification and observation
300 patients without severe malnutrition, without other cardiovascular diseases, liver, kidney and hematopoietic systems, without serious systemic diseases and drug allergy history and distributed in all age groups are selected for administration, and taken twice a day for two days. And judging the curative effect of the medicine according to the symptom change of the patient. Wherein, the cure standard is: symptoms such as thirst, sweat, cough, expectoration, asthma and the like disappear, the body temperature is normal, and various indexes are normal; the standard with obvious effect is: the symptoms such as thirst, sweat, cough, expectoration, asthma and the like are mostly disappeared, and the abnormal physicochemical indexes are close to normal; the standard with certain effect is: symptoms such as thirst, sweat, cough, expectoration, asthma and the like are partially disappeared, and abnormal physicochemical indexes are improved; the criteria for invalidation were: not meeting the above criteria.
The test results are shown in table 1 below:
TABLE 1 detection of efficacy of the pharmaceutical agents prepared in examples 1-4 and comparative examples 1-2
Out of 300 cases, 174 were in men and 126 in women. As can be seen from the results in Table 1, the cure rate of both men and women is over 95% after two days of administration in the four examples, and as can be seen from the data in comparative examples 1 and 2, the use of the beta-cyclodextrin and its modified derivatives for auxiliary extraction is beneficial to the complete utilization of active substances in the traditional Chinese medicine, beneficial to the pharmacodynamic action and reduction of cure time.
In the description of the present specification, the descriptions of the terms "one embodiment," "example," "specific example," and the like, mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the present invention. In this specification, schematic representations of the above terms do not necessarily refer to the same embodiments or examples. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The foregoing is merely illustrative and explanatory of the invention, as various modifications and additions may be made to the particular embodiments described, or in a similar manner, by those skilled in the art, without departing from the scope of the invention or exceeding the scope of the invention as defined in the claims.
Claims (5)
1. A traditional Chinese medicine for treating cough and reducing sputum caused by liver-lung yin deficiency is characterized by comprising the following raw materials in parts by mass:
4-8 parts of fritillaria cirrhosa, 1-5 parts of cassia twig, 1-3 parts of schisandra chinensis, 1-3 parts of paeonia lactiflora and 7-95 parts of auxiliary materials.
2. The cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by yin deficiency of liver and lung according to claim 1, wherein the preparation method comprises the following steps:
s1, washing the traditional Chinese medicine materials with deionized water for 3 times, cutting into blocks, sun-drying, then crushing into coarse powder, sieving with a 80-mesh sieve to obtain composite traditional Chinese medicine powder, and storing at 4 ℃ for later use;
s2, soaking the composite traditional Chinese medicine powder in deionized water at room temperature for 1 hour, then adding auxiliary materials, stirring at a speed of 30rpm until the mixture is uniform, and performing condensation reflux operation to obtain an aqueous extract of the composite traditional Chinese medicine;
s3, spray drying the composite traditional Chinese medicine aqueous extract, wherein the temperature of an inlet is set to 80 ℃, the temperature of an outlet is set to 40 ℃, collecting dry powder, and preparing pills to obtain the cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by yin deficiency of liver and lung.
3. The traditional Chinese medicine for treating cough and phlegm caused by liver-lung yin deficiency according to claim 2, wherein in the step S2, the mass ratio of the composite traditional Chinese medicine powder to deionized water is (75-80): 800, the condensation reflux time was 2 hours.
4. The traditional Chinese medicine for treating cough and phlegm caused by yin deficiency of liver and lung according to claim 1, wherein the auxiliary materials are one or more of alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
5. The cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by yin deficiency of liver and lung according to claim 4, wherein the hydroxypropyl-beta-cyclodextrin is prepared by the following steps:
stirring NaOH solution at 30rpm, heating to 60 ℃, adding beta-cyclodextrin while keeping stirring, continuing stirring until the beta-cyclodextrin is completely dissolved, cooling the system to room temperature, then dropwise adding propylene oxide while stirring under ice bath, reacting for 3 hours, heating to room temperature, continuing stirring until an oil layer disappears, regulating the pH value of the system to 6-7 by using HCl solution, then distilling the mixed solution at 45 ℃ under reduced pressure to obtain slurry, dissolving the slurry by using 95% ethanol solution, continuing stirring for 30 minutes, filtering, discarding the precipitate, distilling the filtrate at 45 ℃ under reduced pressure until the volume is 1/3 of the volume, dialyzing with water for 3 hours, then standing at 45 ℃ again under reduced pressure, washing the obtained concentrated slurry by acetone, and drying to obtain the hydroxypropyl-beta-cyclodextrin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310497253.3A CN116549555A (en) | 2023-05-05 | 2023-05-05 | Cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by liver-lung yin deficiency |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310497253.3A CN116549555A (en) | 2023-05-05 | 2023-05-05 | Cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by liver-lung yin deficiency |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116549555A true CN116549555A (en) | 2023-08-08 |
Family
ID=87502981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310497253.3A Pending CN116549555A (en) | 2023-05-05 | 2023-05-05 | Cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by liver-lung yin deficiency |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116549555A (en) |
-
2023
- 2023-05-05 CN CN202310497253.3A patent/CN116549555A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107050148B (en) | Traditional Chinese medicine composition for dispelling effects of alcohol and protecting liver and preparation method thereof | |
WO2013102410A1 (en) | Oral liquid for treating allergic cough | |
JPH045652B2 (en) | ||
CN107303303B (en) | Prepare Tongkat Ali active ingredient and combination application | |
CN112675278A (en) | Composition for moistening lung to arrest cough and inhibiting lung inflammatory reaction and preparation method and application thereof | |
CN106581166A (en) | Anti-fatigue food, health product or pharmaceutical composition | |
CN100509856C (en) | Cryptoporus volvatus polysaccharide, preparation and application thereof | |
CN114404462B (en) | Composition and application thereof in preparation of medicine for treating gastric injury and/or gastric ulcer | |
CN116549555A (en) | Cough relieving and phlegm reducing traditional Chinese medicine for treating cough caused by liver-lung yin deficiency | |
CN114652812A (en) | Composition for treating alcoholic gastric injury and gastric ulcer and preparation method and application thereof | |
CN101234139B (en) | Proprietary Chinese medicine for curing common cold and preparation thereof | |
KR100815277B1 (en) | Antihyperlipidemia Agent Comprising Red Ginseng Acid Polysaccharide and Lycium Chinense Extract | |
CN107669795B (en) | Composition for relieving chemical liver injury caused by alcohol | |
CN113288993A (en) | Compound low-temperature vacuum drying extraction powder and extraction method thereof | |
CN100488543C (en) | Local externally applied itch stopping garlic liniments | |
CN106188083B (en) | A method of extracting 1, 8-Cineole volatile oil from folium artemisiae argyi | |
CN116211993B (en) | Composition for treating senile chronic disease and its preparation method | |
CN109820924A (en) | A kind of preparation method of the separation and Extraction effective component from grape pip | |
CN115400171B (en) | Traditional Chinese medicine composition for treating wind-cold type common cold and preparation method thereof | |
CN108339051A (en) | A kind of drug that treating chemical damage, preparation method and applications | |
CN113101331B (en) | Thyme herb tea and preparation method and application thereof | |
CN107596145B (en) | Preparation method of compound dendrobium officinale extractum | |
CN114191532B (en) | Uric acid reducing composition, preparation method and application thereof | |
JP7479537B1 (en) | Carob polysaccharides for relieving cough, reducing phlegm and improving immunity and their preparation method and use | |
CN107811907A (en) | A kind of body lotion for promoting subcutaneous fat to decompose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |